Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

Genes and Development

Volumn 12, Issue 13, 1998, Pages 2061-2072

  Ronco, Lucienne V ^a   Karpova, Alla Y ^a   Vidal, Marc ^b   Howley, Peter M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

HPV16; IRF 3; Oncoprotein; Protein protein interactions; Transcription

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; INTERFERON REGULATORY FACTOR 3; ONCOPROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; TRANSACTIVATION; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 0032128003     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.13.2061     Document Type: Article

References (69)

1. Androphy, E.J., N.L. Hubbert, J.T. Schiller, and D.R. Lowy. 1987. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 6: 989-992.
2. Au, W.C., P.A. Moore, W. Lowther, Y.T. Jaung, and P.M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. 92: 11657-11661.
3. Band, V., S. Dalal, L. Delmolino, and E.J. Androphy. 1993. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6 immortalized human mammary epithelial cells. EMBO J. 12: 1847-1852.
4. Bhattacharya, S., R. Eckner, S. Grossman, E. Oldread, Z. Arany, A. D'Andrea, and D.M. Livingston. 1996. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383: 344-347.
5. Bosch, F.X., M.M. Manos, N. Munoz, M. Sherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, K.V. Shah, E. Alihonou, S. Bayo, H.C. Mokhtar, S. Chicareon, A. Daudt, E. Delosrios, P. Ghadirian, J.N. Kitinya, M. Koulibaly, C. Ngelangel, L.M.P. Tintore, J.L. Riosdalenz, A. Sarjadi-Schneider, L. Tafur, A.R. Teyssie, P.A. Rolon, M. Torroella, A.V. Tapia, H.R. Wabinga, W. Zatonski, B. Sylla, P. Vizcaino, D. Magnin, J. Kaldor, C. Greer, and C. Wheeler. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide pespective. J. Natl. Cancer Inst. 87: 796-802.
6. Bovolenta, C., P. Driggers, M. Marks, J. Medin, A. Politis, S. Vogel, D. Levy, K. Sakaguchi, E. Appella, J. Coligan, and K. Ozato. 1994. Molecular interactions between interferon consensus sequence-binding protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. 91: 5046-5050.
7. Brutkiewiewicz, R.R. and R.M. Welsh. 1995. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69: 3967-3971.
8. Chen, J.J., C.E. Reid, V. Band, and E.J. Androphy. 1995. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269: 529-531.
9. Crook, T., J.A. Tidy, and K.H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 building and transactivation. Cell 67: 547-556.
10. De Maeyer, E. and J. De Maeyer-Guignard. 1988. Interferons and other regulatory cytokines. John Wiley and Sons, New York, NY.
11. Deng, T. and M. Karin. 1993. JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes & Dev. 7: 479-490.
12. Desaintes, C., S. Hallez, P. Van Alhen, and A. Burney. 1992. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66: 325-333.
13. Dey, A., I.A. Atcha, and S. Bagchi. 1997. HPV16 E6 oncoprotein stimulates the transforming growth factor-β1 promoter in fibroblasts through a specific GC-rich sequence. Virology 228: 190-199.
14. Dowhanick, J.J., A.A. McBride, and P.M. Howley. 1995. Suppression of cellular proliferation by the papillomavirus E2 protein. J. Virol. 69: 7791-7799.
15. Driggers, P.H., B.A. Elenbaas, J.-B. An, I.J. Lee, and K. Ozato. 1992. Two upstream elements activate transcription of major histocompatibility complex class I gene in vitro. Nucleic Acids Res. 20: 2533-2540.
16. Eisenbeis, C., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes & Dev. 9: 1377-1387.
17. Elston, R.C., S. Napthine, and J. Doorbar. 1998. The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP, E6BP. J. Gen. Virol. 79: 371-374.
18. Etscheid, B.G., S.A. Foster, and D.A. Galloway. 1994. The E6 protein of Human Papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53. Virology 205: 583-585.
19. Frazer, I.H. 1996. Immunology of papillomavirus infection. Curr. Opin. Immunol. 8: 484-491.
20. Fujita, T., Y. Kimura, M. Miyamoto, H. Yamamoto, K. Harada, M. Ishihara, and T. Taniguchi. 1989. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 337: 270-272.
21. Halbert, C.L., G.W. Demers, and D.A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65: 473-478.
22. Harada, H., K. Willison, J. Sakakibara, M. Miyamoto, T. Fujita, and T. Taniguchi. 1990. Absence of the type 1 IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63: 303-312.
23. Harada, H., M. Kitagawa, N. Tanaka, H. Yamamoto, K. Harada, M. Ishihara, and T. Taniguchi. 1993. Anti-oncogenic and oncogenic potentials of interferon regulatory factors -1 and -2. Science 259: 971-974.
24. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor Laboratory, NY.
25. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71: 543-546.
26. Howley, P.M. 1996. Papillomavirinae: The viruses and their replication. In Fundamental Virology (ed. D.M.K. Bernard, N. Fields, and P.M. Howley), pp. 2045-20076. Lippincott-Raven, Philadelphia, PA.
27. Hudson, J.B., M.A. Bedell, D.J. McCance, and L.A. Laimins. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64: 519-526.
28. Huibregtse, J.M., M. Scheffner, and P.M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10: 4129-4135.
29. _. 1993a. Cloning and expression of the cDNA for E6-AP: A protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13: 775-784.
30. _. 1993b. Localization of the E6-AP regions that direct HPV E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918-4927.
31. Jones, D.L. and K. Münger. 1996. Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin. Cancer Biol. 7: 327-337.
32. Kim, T.K. and T. Maniatis. 1997. The mechanism of viral transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1: 119-129.
33. Kinoshita, T., H. Shirasawa, Y. Shino, H. Moriya, L. Desbarats, M. Eilers, and B. Simizu. 1997. Transactivation of prothymosin α and c-myc promoters by Human Papillomavirus type 16 E6 protein. Virology 232: 53-61.
34. Klingelhutz, AJ., S.A. Foster, and J.K. McDougall. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-81.
35. Lamberti, C., L.C. Morrissey, S.R. Grossman, and E.J. Androphy. 1990. Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J. 9: 1907-1913.
36. Lechner, M.S., D.H. Mack, A.B. Finicle, T. Crook, K.H. Vousden, and L.A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11: 3045-3052.
37. Levy, D., D. Kessler, R. Pine, and J. Darnell. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative control. Genes & Dev. 2: 383-393.
38. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 847-849.
39. Mietz, J.A., T. Unger, J.M. Huibregtse, and P.M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 oncoprotein. EMBO J. 11: 5013-5020.
40. Miller, A.D. and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-987.
41. Mittrucker, H.-W., T. Matsuyama, A. Grossman, T.M. Kundig, J. Potter, A. Shahinian, A. Wakeman, B. Patterson, P.S. Ohashi, and T.W. Mak. 1997. Requirment for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
42. Muller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
43. Münger, K., W.C. Phelps, V. Bubb, P.M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63: 4417-4421.
44. Nelson, N., M. Marks, P. Driggers, and K. Ozato. 1993. Interferon consensus sequence binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol. Cell. Biol. 13: 588-599.
45. Pan, H. and A.E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 and E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes &. Dev. 8: 1285-1299.
46. Reis, L., H. Harada, J. Wolchok, T. Tanaguchi, and J. Vilcek. 1992. Critical role of a common transcription factor, IRF-1, in the regulation if IFN-α and IFN-β inducible genes. EMBO J. 11: 185-193.
47. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteosome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771.
48. Sadowski, I. and M. Ptashne. 1989. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17: 7539-7540.
49. Sakai, H., T. Yasugi, J.D. Benson, J.J. Dowhanick, and P.M. Howley. 1996. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J. Virol. 70: 1602-1611.
50. Schafer, S.L., R. Lin, P.A. Moore, J. Hiscott, and P.M. Pitha. 1998 Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273: 2714-2720.
51. Scheffner, M., K. Munger, J.C. Byrne, and P.M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. 88: 5523-5527.
52. Sedman, S.A., M.S. Barbosa, W.C. Vass, N.L. Hubbert, J.A. Hass, D.R. Lowy, and J.T. Schiller. 1991. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol 65: 4860-4866.
53. Sherman, L. and R. Schlegel. 1996. Serum-and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol. 70: 3269-3279.
54. Shino, Y., H. Shirasawa, T. Kinoshita, and B. Simizu. 1997. Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complexes binding to the cylclic AMP response element. J. Virol 71: 4310-4318.
55. Shirasawa, H., M. Jin, K. Shimizu, N. Akutsu, Y. Shino, and B. Simizu. 1994. Transcription-modulatory activity of full-length E6 and E6*I proteins of Human Papillomavirus type 16. Virology 203: 36-42.
56. Tamura, T., M. Ishihara, M.S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T.W. Mak, S. Taki, and T. Taniguchi. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599.
57. Tanaka, N., M. Ishihara, M. Kitagawa, H. Harada, T. Kimura, T. Matsuyama, M. Lampier, S. Aizawa, T. Mak, and T. Taniguchi. 1994. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839.
58. Tanaka, N., M. Ishihara, M.S. Lampier, H. Nozawa, T. Matsuyama, T.W. Mak, S. Aizawa, T. Tokino, M. Oren, and T. Taniguchi. 1996. Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818.
59. Thanos, D. and T. Maniatis. 1995. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell 83: 1091-1100.
60. Tong, X. and P.M. Howley. 1997. The papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl Acad. Sci. 94: 4412-4417.
61. Vaughan, P.S., F. Aziz, A.J. van Wijnen, S. Wu, H. Harada. T. Taniguchi, K.J. Soprano, J.L. Stein, and G.S. Stein. 1995. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 377: 362-365.
62. Vilcek, J. and G.S. Sen. 1996. Interferons and other cytokines. In Fields virology, 3rd. ed. (ed. B.N. Fields, P. M. Howley, and D.M. Knipe), pp. 375-400. Raven Press, New York, NY.
63. Wathelet, M., P.M. Berr, and G.A. Huez. 1992. Regulation of gene expression by cytokines and virus in human cells lacking the type-1 interferon locus. Eur. J. Biochem. 206: 901-910.
64. Wathelet, M., C.H. Lin, B. Parekh, L.V. Ronco, P.M. Howley, and T. Maniatis. (1998). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1: 507-518.
65. Weaver, B.K., K. Prasanna Kumar, and N.C. Reich. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18: 1359-1386.
66. Werness, B.A., A.J. Levine, and P.M. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
67. Yasugi, T., J.D. Benson, H. Sakai, M. Vidal, and P.M. Howley. 1997. Mapping and characterization of the interaction domains of human papillomavirus type 16 E1 and E2 proteins. J. Virol. 71:891-899.
68. Zhang, L. and J.S. Pagano. 1997. IRF-7, a new interferon regulatory factor associated with epstein-barr virus latency. Mol. Cell. Biol. 17: 5748-5757.
69. zur Hausen, H. 1996. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta 1288: F55-F78.